Sheaffer, A.K., Mulherin, H.M., Chen, C., Dunaj, C.V., Lee, M.S., Franco, D.L., Campbell, J., Sit, S. Characterization of HCVreplicons resistant to inhibitors of NS3 protease activity. Proceedings of the 7th International Symposiu. 2004. . . Find at Google Scholar.
Tong X, Bogen S, Chase R, Girijavallabhan V, Guo Z, Njoroge FG, Prongay A, Saksena A, Skelton A, Xia. Characterization of resistance mutations against HCV ketoamide protease inhibitors.. Antiviral Res.. 2008. 77(3). 177-185. Find at Google Scholar.
Liverton NJ, Carroll SS, Dimuzio J, Fandozzi C, Graham DJ, Hazuda D, Holloway MK, Ludmerer SW, McCau. MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease. . Antimicrob Agents Chemother. 2010. 54(1). 305-311. Find at Google Scholar.
Vermehren J, Susser S, Lange CM, Forestier N, Karey U, Hughes E, Ralston R, Tong X, Zeuzem S, Sarraz. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boc. J Viral Hepat. . 2012. 19(2). 120-127. Find at Google Scholar.